News · Heart & Metabolic
Losing a tenth of body weight tracked seven times the odds of cirrhosis recovering
Decompensated cirrhosis is treated as one-way: once the liver fails, the list is transplant or palliation. Among 344 patients, 64 climbed back out, and weight loss was the strongest thing separating them.
- Nearly one patient in five recovered from a stage of liver disease treated as final.
- Losing at least a tenth of body weight was the strongest factor separating them.
- Recovery took a median of 15 months, so this is slow rather than dramatic.
- Patients whose liver disease involved alcohol died at nearly twice the rate.
- 344 patients followed about four years, and nobody was assigned to lose weight.
Decompensated cirrhosis is where liver medicine turns grim. The scarring has advanced far enough that the organ starts visibly failing: fluid fills the abdomen, veins in the gullet swell and bleed, toxins the liver should clear reach the brain.
For most of the history of the field this has been treated as a one-way door. Once a patient decompensates, the conversation moves to transplant assessment and to how long they have.
Writing in Hepatology, researchers followed 344 patients with steatotic liver disease-related cirrhosis and counted how many came back. Sixty-four did.
Coming back out
18.6% achieved recompensation, the term for those failures resolving and staying resolved.
It happened at a median of 15 months, across a follow-up of about four years. That timing matters for how the finding should be read: this is not a dramatic reversal but a slow climb, over more than a year, in patients who mostly did not know it was possible.
The category itself is new enough that the number is worth having. Recompensation only acquired a formal definition recently, which is a large part of why nobody could previously say how often it happens.
The factor that stood out
Adjusted for how sick each patient was at baseline, one thing separated the recovered from the rest by a wide margin.
Weight loss of 10% or more carried roughly seven times the likelihood of recompensating. Absence of large esophageal varices, a marker of pressure in the portal vein, roughly doubled it.
Seven-fold is an enormous figure for an observational finding, and it is exactly the size that should make a reader suspicious rather than excited.
Why the obvious reading is probably wrong
Decompensation is defined partly by ascites: fluid accumulating in the abdomen because the failing liver can no longer keep it in the blood vessels.
That fluid weighs a great deal. Several kilograms is ordinary, more is common, and draining it is a routine procedure. A patient whose liver starts working better loses the fluid, and the scale registers a large drop.
So the arrow plausibly runs backwards. Weight loss may not be producing recompensation; recompensation may be producing the weight loss, mechanically, because the water leaves.
The authors adjusted for baseline severity, which helps and does not settle it. Nobody was assigned to lose weight, and no observational analysis can separate the patient who lost fat from the patient who lost fluid.
The alcohol split
The cohort divided almost evenly between the purely metabolic form of the disease and the form where alcohol also contributes.
Recompensation rates were close: 17.7% and 19.4%. Survival was not. Mortality was 12.0% in the metabolic group against 22.6% where alcohol was involved, nearly double.
Alcohol also showed up in the biochemistry. A blood marker of recent drinking was negative in every patient in the metabolic group and positive in around seven in ten of the others, which is a useful reminder that self-reported abstinence and actual abstinence are different measurements.
What cirrhosis is doing meanwhile
Cirrhosis is scarring of the liver caused by long-term damage, and the scar tissue does not conduct blood or perform the liver’s chemistry. Where that damage comes from has shifted: fatty liver disease driven by weight and metabolic health now rivals alcohol as a cause in wealthy countries.
Which makes the population studied here the growing one, and makes the question of whether their disease can be turned around more than academic.
What would settle the weight question
A trial. Specifically, one that assigns supervised weight management to patients with decompensated cirrhosis and follows recompensation, distinguishing fat loss from fluid loss by body composition rather than by the scale.
That trial would need care. Malnutrition and muscle wasting are common in advanced liver disease and both predict worse outcomes, so unsupervised weight loss in this group can do harm. This is not a finding anyone should act on alone.
What it establishes, independent of the weight question, is the more important thing: for roughly one patient in five, the door was not one-way.
People also ask
What did the study find?
Of 344 patients with steatotic liver disease-related cirrhosis, 64 (18.6%) achieved recompensation at a median of 15 months over 3.9 years of follow-up. In competing-risk regression adjusted for baseline MELD-Na, weight loss of 10% or more was associated with recompensation (sHR 7.42; 95% CI 3.15-17.47), as was absence of large esophageal varices (sHR 1.97; 1.22-3.99).
What does decompensated mean?
That the liver has failed at one of its jobs visibly: fluid in the abdomen, bleeding from swollen veins, confusion from toxins the liver no longer clears, or jaundice. It marks the point where survival without a transplant drops sharply.
And recompensation?
Climbing back out: those failures resolving and staying resolved off the treatments that were controlling them. It has only recently been formally defined, which is part of why so little is known about who achieves it.
Does weight loss cause the recovery?
This cannot show that. Nobody was assigned to lose weight, and patients whose livers are recovering may lose weight for that reason rather than the other way round. Fluid loss alone changes the number on the scale in this condition.
Why does that reverse-causation point matter so much here?
Because ascites, the fluid accumulation that defines decompensation, can weigh several kilograms. A patient whose ascites resolves loses weight because they recompensated. Distinguishing that from weight loss driving recovery needs a trial.
What was the difference between the two groups?
Recompensation rates were similar, 17.7% in the metabolic form and 19.4% where alcohol was also involved. Mortality was not: 12.0% versus 22.6%.
What should a patient take from this?
That this stage is not universally one-way, which is worth knowing. Weight management in advanced liver disease is dangerous to attempt unsupervised, since malnutrition is common and muscle loss worsens outcomes. This is general information rather than medical advice.